Opioid receptor binding agents and uses thereof

Jan Steyaert; Toon Laeremans; Els Pardon; Brian K Kobilka; Aashish Manglik

Opioid receptor binding agents and uses thereof

Jan Steyaert (Uitvinder), Toon Laeremans (Uitvinder), Els Pardon (Uitvinder), Brian K Kobilka (Uitvinder), Aashish Manglik (Uitvinder)

Onderzoeksoutput: Patent

Samenvatting

Agents that specifically bind to an opioid receptor in a conformationally specific way can be used to induce a conformational change in the receptor. Such agents have therapeutic applications and can be used in X-ray crystallography studies of the receptor. Such agents can also be used to improve drug discovery via compound screening and/or structure-based drug design.

Originele taal-2	English
Octrooinummer	US10233241
Status	Published - 2019

Andere bestanden en links

https://worldwide.espacenet.com/patent/search/family/052434839/publication/US10233241B2?q=US10233241

Citeer dit

@misc{d2e0a6d803994ff9a036a9d02d999a1a,

title = "Opioid receptor binding agents and uses thereof",

abstract = "Agents that specifically bind to an opioid receptor in a conformationally specific way can be used to induce a conformational change in the receptor. Such agents have therapeutic applications and can be used in X-ray crystallography studies of the receptor. Such agents can also be used to improve drug discovery via compound screening and/or structure-based drug design.",

author = "Jan Steyaert and Toon Laeremans and Els Pardon and Kobilka, {Brian K} and Aashish Manglik",

year = "2019",

language = "English",

type = "Patent",

note = "US10233241",

}

TY - PAT

T1 - Opioid receptor binding agents and uses thereof

AU - Steyaert, Jan

AU - Laeremans, Toon

AU - Pardon, Els

AU - Kobilka, Brian K

AU - Manglik, Aashish

PY - 2019

Y1 - 2019

N2 - Agents that specifically bind to an opioid receptor in a conformationally specific way can be used to induce a conformational change in the receptor. Such agents have therapeutic applications and can be used in X-ray crystallography studies of the receptor. Such agents can also be used to improve drug discovery via compound screening and/or structure-based drug design.

AB - Agents that specifically bind to an opioid receptor in a conformationally specific way can be used to induce a conformational change in the receptor. Such agents have therapeutic applications and can be used in X-ray crystallography studies of the receptor. Such agents can also be used to improve drug discovery via compound screening and/or structure-based drug design.

UR - https://worldwide.espacenet.com/patent/search/family/052434839/publication/US10233241B2?q=US10233241

M3 - Patent

M1 - US10233241

ER -

Opioid receptor binding agents and uses thereof

Samenvatting

Andere bestanden en links

Vingerafdruk

Citeer dit